WHO Statement on Depot-medroxyprogesterone acetate (DMPA)

The purpose of this Statement is to reiterate and clarify the existing (current) WHO position based on published guidance that is still valid. WHO monitors the evidence in this field closely and will update its guidance as and when new evidence becomes available.